-The Indian Express Cash transfers seem to be the latest fad. With elections looming, the Prime Minister’s National Committee on Direct Cash Transfers has been tasked with an ambitious mandate to provide vision and direction to enable direct cash transfers of subsidies under various government schemes and programmes to individuals to enhance efficiency. Certain activists warn against an ill-considered and hasty transition from Food to cash. Others believe directly transferring the...

-The Economic Times The government's ambitious plan for direct cash transfer of subsidies is facing implementation hurdles even as Prime Minister Manmohan Singh on Monday set a January 1 deadline to roll out the scheme in 51 districts. While the PM's announcement was a formality, the petroleum ministry has pointed out that once the Cabinet approves the new mechanism on oil and LPG subsidies, it will take 11 months for a rollout. This...

-The Indian Express The UPA has long been planning a shift to direct cash transfers for poor households, with a view to replacing the 3.23 lakh crore worth of unwieldy subsidies currently in place. Last year, the then finance minister Pranab Mukherjee had spoken of the famously inefficient Food and fertiliser subsidies, and of a comprehensive overhaul through cash transfers. Now, that plan has been fleshed out further. The prime minister...

-The Times of India The Prime Minister is expected to formally kick off cash transfer of subsidies and entitlements, one of the most ambitious policy initiatives of UPA-2, on Monday. The scheme for cash transfers is visualized as a game-changer for UPA-2, like NREGA was for UPA-1, and is expected to give rich dividends at the elections. Manmohan Singh is expected to set January 1, 2013 as the launch date for the...

-The Times of India A once-a-week medicine for diabetics — a disease that affects nearly 63 million Indians — could soon become a reality. Studies on diabetes have seen a global upsurge, with the latest data showing that bio-pharmaceutical research companies across the globe are busy developing 221 innovative new medicines. The drugs, which will help around 347 million patients include new therapies that target key abnormalities of pancreatic cells, increase insulin secretion...